Senseonics Holdings Inc. just scored a big win with one of the country’s largest health insurance companies.
The Germantown med-tech firm said Wednesday that Indianapolis-based Elevance Health Inc., formerly Anthem Inc., is now providing coverage for implantable continuous glucose monitoring (CGM) systems — including the local firm’s device, a long-lasting implant that helps diabetes patients manage their blood-sugar levels.
Senseonics’ long-term implant, Eversense, is already included in health plans for about 250 million people, thanks to a growing group of private payors — Cigna Corp., CVS-owned Aetna, Humana and Health Care Service Corp. — now covering the device. Elevance’s decision expands that access to an additional 45 million patients and “demonstrates broad-based coverage across the United States from the majority of commercial payers, enabling their members to access the benefits of the long-term Eversense CGM System,” Senseonics said in its announcement.
The…
Read the full story from the Washington Business Journal.
